A period survival analysis estimates survival under the recent mortality conditions operating during a fixed calendar period. For calendar year 2022, each cancer patient's contribution begins at the later of diagnosis and 1 January 2022, which treats earlier diagnoses as left-truncated at the start of the year. Follow-up ends at death, loss to follow-up, or 31 December 2022, so surviving records are right-censored. Combining these risk-set contributions, commonly through a Kaplan–Meier estimator, constructs the 2022 period survivor function; records from several diagnosis cohorts may contribute different segments of follow-up.
Construct the two countries' period-specific risk sets with the same left truncation and right censoring rules, then compare their event counts by a Log-rank test. This is a nonparametric comparison because it does not specify the shape of either country's hazard function.
Under a country-specific constant hazard survival model, let be the number of deaths and the total person-time at risk in country . The likelihood is proportional to
so the maximum-likelihood estimator is . Test by a likelihood-ratio test, score test, or Wald test; equivalently, give a Poisson distribution with mean and test the country coefficient in a Poisson regression with offset .

Articles by others on the same topic (0)

There are currently no matching articles.